Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2025Cardiovascular Diagnosis and TherapyOpen Access

Blood miRNA-29b is lower in patients with AMI, particularly in those with impaired cardiac function.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does blood miRNA-29b have value in the diagnosis of acute myocardial infarction and the evaluation of postinfarction cardiac function?

Population

Patients with AMI

Authors

XWXiaoxi WangXLXuexin LiuWSWeihua Shao

Discussion

Loading...

Member takes

Overview

May aid AMI diagnosis and postinfarction function assessment; extends miRNA biomarker evidence in acute coronary syndromes.

Structured PICO

Does blood miRNA-29b have value in the diagnosis of acute myocardial infarction and the evaluation of postinfarction cardiac function?

P
Population
Patients with acute myocardial infarction (AMI)
I
Intervention
Blood miRNA-29b measurement
O
Outcome
Diagnosis of AMI and assessment of postinfarction cardiac functionsurrogate

Blood miRNA-29b may serve as a useful biomarker for diagnosing acute myocardial infarction and assessing subsequent cardiac function impairment.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/69d9a6edc7f0c3ae80a3e439https://doi.org/10.21037/cdt-24-561
View Full Paper
Ask AI
Bookmark
Share